«Ehlers-Danlos Syndrome

Below is an extended Ehlers-Danlos Syndrome patents listing. Click here to return to the Ehlers-Danlos Syndrome main in depth entry.

Patents :
US Patent No.	Title
7087745	Three-dimensional structures containing hyaluronic acid derivatives obtained by the supercritical antisolvent technique
7186826	Phosphorus-containing compounds and uses thereof
7186838	Fluorinated 4-azasteroid derivatives as androgen receptor modulators
7189705	Methods of enhancing SPLP-mediated transfection using endosomal membrane destabilizers
7196164	Secreted protein HHTLF25
7208274	Rapid analysis of variations in a genome
7217720	17-heterocyclic-4-azasteroid derivatives as androgen receptor modulators
7220769	Azolylbenzamides and analogues and their use for treating osteoporosis
7232667	Keratinocyte growth factor-2 polynucleotides
7238799	Mustang, a gene and nuclear protein
7250496	Bioinformatically detectable group of novel regulatory genes and uses thereof
7186698	Spatial and temporal control of gene expression using a heat shock protein promoter in combination with local heat
7163797	50 human secreted proteins
7138378	Genetic suppression and replacement
7091213	Phosphorus-containing compounds and uses thereof
7094587	16002 Molecules and uses therefor
7101875	Methods for treating arthritic disorders
7108972	Proteins, polynucleotides encoding them and methods of using the same
7115364	Arrays of nucleic acid probes on biological chips
7115372	Methods for targeting RNA molecules
7115585	Compositions for treating epithelial and retinal tissue diseases
7115589	Purine derivatives
7122345	Nucleic acid encoding a NOVX13 polypeptide
7132427	Quinazolines and uses thereof
7264926	Nucleoside Phosphatase
7267966	Complexity management and analysis of genomic DNA
7368527	HADDE71 polypeptides
7368531	Human secreted proteins
7375198	Modified nucleic acid probes
7378492	CD40-related receptor that binds CD40L
7381800	Antibodies to HBIMF63 polypeptide
7396811	Subcellular targeting of therapeutic proteins
7399584	Method of comparing a target nucleic acid and a reference nucleic acid
7402387	Methods and compositions for detecting dihydropyrimidine dehydrogenase splicing mutations
7410977	Fluorinated 4-azasteroids as androgen receptor modulators
7411051	Antibodies to HDPPA04 polypeptide
7365202	Polymorphs of an androgen receptor modulator
7359748	Apparatus for total immersion photography
7351566	27877, 18080, 14081, 32140, 50352, 16658, 14223, 16002, 50566, 65552, and 65577 molecules and uses therefor
7268153	N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators
7285631	Human cDNAs and proteins and uses thereof
7291461	Methods for identifying small molecules that modulate premature translation termination and nonsense mRNA decay
7312229	21-Heterocyclic-4-azasteroid derivatives as androgen receptor modulators
7320988	Methods of lowering lipid levels in a mammal
7329422	Pharmaceutical compositions
7329490	Methods for diagnosing schizophrenia by detecting a polymorphism in the KalphaM1 gene
7329750	17-Acetamido-4-azasteroid derivatives as androgen receptor modulators
7332277	Methods for detection of genetic disorders
7339049	Polymorphisms in human mitochondrial DNA
7415358	Molecular toxicology modeling

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.